Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.
Fractile is building chips that remove every bottleneck to running large language models at a global scale
Allos is a solution to prognose, monitor, and treat autoimmune conditions.
Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.
Archangel Lightworks builds deployable laser communication systems for the space-enabled networks of the future.
Scripta Therapeutics operates as a bio-tech company.
Valink Therapeutics develops drug discovery programs focused on bispecific antibody-drug conjugates designed for complex disease biology.
Wild Bioscience is a crop improvement company that provides carbon mitigation, yield enhancement, and farm productivity solutions.
Kneu Health transforms smart phones into clinical-grade monitors to keep a tab on neurological conditions like Parkinson’s and dementia.
Oath Surgical operates with distinction, offering our patients, associates, and partners unmatched value and experiences.
Salience Labs provides photonic switch technology and optical networking solutions tailored for AI infrastructure.
FluoRok is revolutionizing the way fluorochemicals are produced globally.
NavLive creates instant 2D and 3D models, along with accurate site surveys using user-friendly Scan-to-BIM functionality.
Porpoise Power develops bio-inspired tidal energy systems delivering predictable, low-impact renewable power from ocean currents.
Mode Labs provide robust, continuous, and remote real-time chemical sensors.
Seloxium is innovative research that makes it possible to extract necessary metals in an environmentally friendly manner.
Alloyed develops, licenses, and manufactures proprietary alloys, alloy powders and alloy components.
Mixergy offer a cost-effective solution to save energy and facilitate more renewable power generation.
Neu Health enables clinicians, caregivers, and patients to tackle this growing challenge with cutting-edge digital technologies.
Perspectum provides imaging solutions to help doctors in clinical decision-making as well as support patient engagement.
natcap is a nature intelligence company that provides report and act on impacts and dependencies on nature.
PQShield is a post-quantum cryptography company that develops cryptographic algorithms and protocols to secure technology infrastructures.
Amber Therapeutics develops the next-generation of bioelectrical therapies.
Oxford Science Enterprises has invested in 134 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Oxford Science Enterprises's top investment sectors include Biotechnology, Health Care, Therapeutics, Artificial Intelligence (AI), Medical. The firm invests across 51 different industry categories.
Among tracked funding rounds, Amber Therapeutics received $101.8M in a Series A round. Oxford Science Enterprises's total known invested capital is $2.2B.
Oxford Science Enterprises's average investment size is $18.0M across its portfolio of 134 companies.
Recent Oxford Science Enterprises portfolio additions include Nucleome Therapeutics, Theolytics, Fractile, Allos, Beacon Therapeutics. These companies were founded in 2020 or later.